1. Home
  2. CYTK vs AGNC Comparison

CYTK vs AGNC Comparison

Compare CYTK & AGNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$60.83

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Logo AGNC Investment Corp.

AGNC

AGNC Investment Corp.

N/A

Current Price

$8.68

Market Cap

12.6B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
AGNC
Founded
1997
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
12.6B
IPO Year
2004
2008

Fundamental Metrics

Financial Performance
Metric
CYTK
AGNC
Price
$60.83
$8.68
Analyst Decision
Buy
Hold
Analyst Count
22
14
Target Price
★ $109.90
$11.06
AVG Volume (30 Days)
1.8M
★ 29.5M
Earning Date
11-04-2026
10-19-2026
Dividend Yield
N/A
★ 16.55%
EPS Growth
N/A
★ 58.06
EPS
N/A
★ 0.37
Revenue
★ $13,368,000.00
N/A
Revenue This Year
$70.12
N/A
Revenue Next Year
$183.63
$22.94
P/E Ratio
★ N/A
$23.47
Revenue Growth
N/A
★ N/A
52 Week Low
$54.30
$8.59
52 Week High
$88.31
$12.19

Technical Indicators

Market Signals
Indicator
CYTK
AGNC
Relative Strength Index (RSI) 24.31 16.57
Support Level $59.05 N/A
Resistance Level $67.04 $11.54
Average True Range (ATR) 2.06 0.18
MACD -0.37 -0.11
Stochastic Oscillator 3.95 6.56

Price Performance

Historical Comparison
CYTK
AGNC

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About AGNC AGNC Investment Corp.

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.

Share on Social Networks: